Literature DB >> 6220469

Lymphoid cell-glioma cell interaction enhances cell coat production by human gliomas: novel suppressor mechanism.

S J Dick, B Macchi, S Papazoglou, E H Oldfield, P L Kornblith, B H Smith, M K Gately.   

Abstract

Certain human glioma lines produce mucopolysaccharide coats that impair the generation of cytolytic lymphocytes in response to these lines in vitro. Coat production is substantially enhanced by the interaction of glioma cells with a macromolecular factor released by human peripheral blood mononuclear cells in culture. This interaction thus constitutes an unusual mechanism by which inflammatory cells may nonspecifically suppress the cellular immune response to at least one class of solid tumors in humans.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6220469     DOI: 10.1126/science.6220469

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  18 in total

1.  Neurological surgery at the National Institutes of Health.

Authors:  Gautam U Mehta; John D Heiss; John K Park; Ashok R Asthagiri; Kareem A Zaghloul; Russell R Lonser
Journal:  World Neurosurg       Date:  2010-07       Impact factor: 2.104

2.  Ultrastructural features of the lymphocyte-stimulated halos produced by human glioma-derived cells in vitro.

Authors:  M A Oberc-Greenwood; L M Muul; M K Gately; P L Kornblith; B H Smith
Journal:  J Neurooncol       Date:  1986       Impact factor: 4.130

3.  Mechanisms of malignant glioma immune resistance and sources of immunosuppression.

Authors:  German G Gomez; Carol A Kruse
Journal:  Gene Ther Mol Biol       Date:  2006

4.  Pilot study of local autologous tumor infiltrating lymphocytes for the treatment of recurrent malignant gliomas.

Authors:  K B Quattrocchi; C H Miller; S Cush; S A Bernard; S T Dull; M Smith; S Gudeman; M A Varia
Journal:  J Neurooncol       Date:  1999       Impact factor: 4.130

5.  In vivo immunization against autologous glioblastoma-associated antigens.

Authors:  A E Eggers; L Tarmin; E T Gamboa
Journal:  Cancer Immunol Immunother       Date:  1985       Impact factor: 6.968

Review 6.  The endothelium--astrocyte immune control system of the brain.

Authors:  A Fontana; W Fierz
Journal:  Springer Semin Immunopathol       Date:  1985

7.  Immune adjuvants for chemotherapy or radiotherapy in the 9L rat brain tumor model.

Authors:  C Liu; B F Kimler; R G Evans; R A Morantz
Journal:  J Neurooncol       Date:  1993-02       Impact factor: 4.130

Review 8.  Lymphokines and the brain.

Authors:  A Fontana; P J Grob
Journal:  Springer Semin Immunopathol       Date:  1984

Review 9.  Invasiveness of primary brain tumors.

Authors:  O D Laerum; R Bjerkvig; S K Steinsvåg; L de Ridder
Journal:  Cancer Metastasis Rev       Date:  1984       Impact factor: 9.264

10.  Intracranial administrations of single or multiple source allogeneic cytotoxic T lymphocytes: chronic therapy for primary brain tumors.

Authors:  C A Kruse; P M Schiltz; D Bellgrau; Q Kong; B K Kleinschmidt-DeMasters
Journal:  J Neurooncol       Date:  1994       Impact factor: 4.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.